Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing ...
26
Description

Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH < 7-3
 • Decreased serum bicarbonate level < 18 mEq/L
 • Relatively low blood glucose level < 200 mg/dL
Pathophysiology of EuDKA

by Gillian Leung, PharmD @GillPillPharmD via @accpcardprn

#Euglycemic #Diabetic #Ketoacidosis #EuDKA #diagnosis #management #endocrinology
Contributed by

Dr. Gerald Diaz
@GeraldMD
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG:  https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Medical jobs
view all

0 Comments

Related content